NL-OMON24461
Not yet recruiting
Not Applicable
Prognostic value of pretreatment imaging parameters for recurrent laryngeal and hypopharyngeal carcinoma after primary radiotherapy; a retrospective study.
MC Utrecht0 sites500 target enrollmentTBD
Conditionsarynx and hypopharynx carcinoma
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- arynx and hypopharynx carcinoma
- Sponsor
- MC Utrecht
- Enrollment
- 500
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with larynx or hypopharynx carinoma primarily treated with radiotherapy with curative intent with or without additional chemotherapy. Treated in UMC Utrecht in the period of January 2008 and March 2020\. Follow\-up of at least 2 years or until recurrence. Available MRI imaging of the tumor site is made within 4 weeks before the start of the radiotherapy treatment.
Exclusion Criteria
- •History of carcinoma at the time of diagnosis. Distant metastasis or second primary tumours at time of diagnosis.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
Radiographic measurement for predicting the risk of periprosthetic tibial plateau fracture after Oxford cementless unicompartmental knee arthroplastycurrently no established radiographic measurement parameter for predicting the risk of periprosthetic tibial plateau fracture following Oxford cementless unicompartmental knee arthroplasty (OUKA)UKA, Periprosthetic fractureTCTR20230722001Paphon Hirunyachoke75
Recruiting
Not Applicable
Prognostic value of imaging biomarkers in patients with hepatocellular carcinoma treated with liver TransplantatioC22.0Liver cell carcinomaDRKS00027969MU München200
Completed
Not Applicable
Prognostic parameter in patients having therapy-related myeloid neoplasms after peptide receptor radionuclide therapy (PRRT) and peptide receptor radioligand therapy (PRLT) over 20 years’ experiencetherapy-related myeloid neoplasmpeptide receptor radionuclide therapyrelated myeloid neoplasm,prognostic factor,peptide receptor radionuclide therapy,overall survival,predictor,myelodysplastic syndromeTCTR20200428005one386
Active, not recruiting
Not Applicable
Examination of prognostic factors for medical treatment of intractable pleural effusion after pediatric cardiac surgeryRefractory pleural effusion after surgeryJPRN-jRCT1031200009Kaneko Yukihiro20
Completed
Not Applicable
Analysis of of the prognostic value of histological subtypes in locally advanced adenocarcinoma of the uterine cervix after carbon-ion radiotherapyterine cervical cancerJPRN-UMIN000028625ational Institute of Radiological Sciences55